Sulfasalazine

CAS No. 599-79-1

Sulfasalazine( Azopyrin | NSC 203730 | NSC 667219 )

Catalog No. M15233 CAS No. 599-79-1

Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG 41 In Stock
1G 49 In Stock

Biological Information

  • Product Name
    Sulfasalazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.
  • Description
    Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent. Target: Others Sulfasalazine (Azulfidine), used to treat pain and swelling in arthritis, belongs to a class of drugs called sulfa drugs.(In Vitro):Treatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.(In Vivo):At low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
  • In Vitro
    Treatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.
  • In Vivo
    At low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
  • Synonyms
    Azopyrin | NSC 203730 | NSC 667219
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1| COX-2| NF-κB
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    599-79-1
  • Formula Weight
    398.39
  • Molecular Formula
    C18H14N4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 80 mg/mL (200.8 mM)
  • SMILES
    O=C(O)C1=CC(/N=N/C2=CC=C(S(=O)(NC3=NC=CC=C3)=O)C=C2)=CC=C1O
  • Chemical Name
    (E)-2-hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Weber CK, et al. Gastroenterology. 2000 Nov;119(5):1209-18.
molnova catalog
related products
  • Thonzylamine

    Thonzylamine is an antihistamine and anticholinergic drug. It is available as combination products with Clofedanol or Phenylephrine for temporary relief of symptoms of common cold, hay fever (allergic rhinitis) or other upper respiratory allergies.

  • Hamaline

    Hamaline is a substrate-selective cyclooxygenase-2 (COX-2) inhibitor.

  • Vitacoxib

    A potent, selective COX-2 inhibitor with IC50 of 0.34 ug/mL.